chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 18.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Blood pressure decreased, Cold sweat, Dizziness, Heart rate decreased, Pallor
Clinical narrative: Case number PHHY2014US152989, is an initial spontaneous report received from the vaccines adverse events reporting system (VAERS reference number: 538032) on 13 Nov 2014. This report refers to an 18 years old male patient. His medical history and concomitant medications were not reported. He received PPD placement for tuberculosis test on 23 Jul 2014. He was vaccinated with MENVEO (batch number: M14021) and also vaccinated with GARDASIL (other manufacturer, batch number: J006850) on 23 Jul 2014. It was reported that when he was walking to waiting room he become dizzy, skin cool, clammy and pale. There was no lack of consciousness. He sat down with his head down. Ice was applied to back of neck. His heart rate was found to be 52 and blood pressure 97/54. After 5 minutes skin color retained, had some (AJ) drink. The outcome of the events was reported as complete recovery. The health authority reported that the events were non-serious and causality of the events was not reported.
Age: 18.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Tuberculin test
Clinical narrative: Case number PHHY2014US152989, is an initial spontaneous report received from the vaccines adverse events reporting system (VAERS reference number: 538032) on 13 Nov 2014. This report refers to an 18 years old male patient. His medical history and concomitant medications were not reported. He received PPD placement for tuberculosis test on 23 Jul 2014. He was vaccinated with MENVEO (batch number: M14021) and also vaccinated with GARDASIL (other manufacturer, batch number: J006850) on 23 Jul 2014. It was reported that when he was walking to waiting room he become dizzy, skin cool, clammy and pale. There was no lack of consciousness. He sat down with his head down. Ice was applied to back of neck. His heart rate was found to be 52 and blood pressure 97/54. After 5 minutes skin color retained, had some (AJ) drink. The outcome of the events was reported as complete recovery. The health authority reported that the events were non-serious and causality of the events was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US152991, is an initial spontaneous report received from the vaccines adverse events reporting system (VAERS reference number: 538146) on 13 Nov 2014. This report refers to an 18 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: X14023) intramuscularly in the right arm on 22 Jul 2014. On 24 Jul 2014, she experienced warmth, redness and swelling approximately 50 mm in diameter at injection site. She also experienced slight itching and tender to touch at the injection site. The outcome of the events redness and swelling at injection was reported as complete recovery by 30 Jul 2014 and for the other events was reported as complete recovery. The health authority reported that the events were non-serious and causality of the events was not reported.
Age: 12.0
Sex: F
Vaccine: MEN, TDAP
Symptoms: Pain, Peripheral swelling
Clinical narrative: Case number PHHY2014US120543, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 538195) website on 16 Sep 2014. This report refers to a 12-year-old female patient. Past medical history and concomitant medications were not reported. She was vaccinated with meningococcal vaccine (manufacturer and batch number unknown) and TDAP (manufacturer and batch number unknown) both on 28 Jul 2014. On 30 Jul 2014, her left arm swollen up and experienced pain. Outcome of the events was reported as condition unchanged as of 30 Jul 2014. Seriousness and causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Urticaria
Clinical narrative: Case number PHHY2014US153166 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 538289) website on 13 Nov 2014. This report refers to an 11 years old female patient. Her current condition included pencillin allergy and her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A14040) in the right arm, GARDASIL (batch number: J010668) in left arm and BOOSTRIX (other manufacturer, batch number: 4JL44) in the left arm on 18 Jul 2014. On 21 Jul 2014, hives broke out in her ankles, right flank and waistline. She had treatment with Hydroxyzine and Triamcinolone. The outcome was reported as unknown. The event was reported as non-serious. The causality of the event was not reported.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Discomfort, Erythema
Clinical narrative: Case number PHHY2014US153317, is an initial spontaneous report received from the vaccines adverse reporting system (VAERS reference number: 538555) on 13 Nov 2014. This report refers to a 12 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M14023) intramuscularly in right arm on 22 Jul 2014. He was also vaccinated with ADACEL (other manufacturer, batch number: U4902BA) intramuscularly in left arm on 22 Jul 2014. On 23 Jul 2014, he experienced redness and mild discomfort. The outcome of the events was reported as known. The health authority reported that the events were non-serious and causality of the events was not reported.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US153043, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 538556) website on 13 NOV 2014. This report refers to a 12 years old female patient. Past medical history and concomitant medication were not reported. She was vaccinated with  MENVEO (batch number: M14023), intramuscularly in the left arm on 23 JUL 2014. On 24 JUL 2014, she experienced swelling in upper left shoulder site is warm to touch and redden and also complained of pain. The outcome of the events was reported as unknown. The seriousness of the event was reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus
Clinical narrative: Case number PHHY2014US153055, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 538742) website on 13 NOV 2014. This report refers to an 11 year old male patient. Past medical history and concomitant medication were not reported. Previously, he was vaccinated with DTaP (manufacturer and batch number: unknown), at the age of 5 years. He was vaccinated with MENVEO (batch number: X14023), subcutaneously in the left arm and BOOSTRIX (other manufacturer, batch number: 7KM4D), intramuscularly in the right arm on 24 JUL 2014. Approximately 24 hours after the vaccination, on 25 JUL 2014, he experienced erythematous indurated area on left deltoid and improved 28 JUL 2014, but still itchy with slight erythema. The outcome of the events was reported as complete recovery. The seriousness of the event was reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site reaction, Pruritus, Skin lesion
Clinical narrative: Case number PHHY2014US154343 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 538750) website on 13 NOV 2014. This report refers to an 11 year old male patient. His medical history included skin infections. His current condition included sensitive skin and allergic rhinitis. His concomitant medications included Claritin. He was vaccinated with MENVEO (batch number: M13030) and ADACEL (other manufacturer, batch number: C4506BA); both vaccines administered intramuscularly in the right left (in thigh) on 23 JUL 2014. On 24 JUL 2014, he experienced 5 cm x 6 cm erythematous lesion without distinct borders in his right thigh. He had no pain or streaking. Antibiotics were given whenever required and the symptoms were worsening. He also had itching and he used antihistamine whenever required. The outcome was reported as unknown. The events were reported as non-serious. The causality of the events was not reported. Following and internal review on 26 NOV 2014 of the date received on 13 NOV 2014, it was identified that the verbatim "5 cm x 6 cm erythematous lesion without distinct borders in his right thigh" was erroneously coded as skin lesion and hence the event was now deleted.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Eye swelling
Clinical narrative: Case number PHHY2014US148640, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 538766) website on 13 NOV 2014. This report refers to an 11-year-old female patient. Past medical history and concomitant medication were not reported. She was vaccinated with MENVEO (batch number: A14031) in the left arm and BOOSTRIX (other manufacturer, batch number: 7KM4D), in the right arm on 31 JUL 2014. On the same day after vaccination, she experienced one eye swelling. The outcome of the event was reported as completed recovered. The seriousness of the event was reported as non-serious. The causality of the event was not reported.
Age: 19.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Pyrexia
Clinical narrative: Case number PHHY2014US153075, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 538773) website on 13 NOV 2014. This report refers to a 19 years old female patient. Past medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A12104) intramuscularly in the right arm on 13 JUL 2014. On 01 AUG 2014, she experienced redness at injection site and used ice packs. She also experienced fever and treated with ibuprofen and BENADRYL. She spoke to her doctor and they said to continue this treatment. The outcome of the events was reported as unknown. The seriousness of the events was reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US153321, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 538846) on 13 NOV 2014. This report refers to an 11  years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: A14040) intramuscularly in the left arm on 22 JUL 2014. It was reported that on 22 JUL 2014, he presented with swelling on lateral aspect of left upper arm which was pink, hard and warmth of 18 x 15 cm. The outcome of the events was reported as complete recovery. The health authority reported that the events were non-serious and causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Dizziness
Clinical narrative: Case number PHHY2014US135357, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 538912) website on 10 OCT 2014. This report refers to an 11-year-old male patient. Historical conditions were none. Concomitant medications were none. He was vaccinated with MENVEO (batch number: A13051) into the left arm along with BOOSTRIX (batch  number: 7KM4D) into the left arm intramuscularly on 05 AUG 2014. On the same day, after vaccination, be became dizzy and lightheaded. At checkout be bumped his chin on the counter with no apparent injury. He was placed in a chair and later on exam table to take vital signs. Ice was applied and he denied complaints and left in ten minutes after the same. The final outcome of the event was complete recovery. The event was reported as non-serious, causality was not reported.
Age: 14.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US137362, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 538964) website on 10 Oct 2014. This report refers to a 14 year old female patient. Her medical history reported that she was allergic to pecans (develops itchy throat); asthma diagnosed 2 years ago; chronic constipation since 6 months of age; dyslexia and ADHD (attention deficit/hyperactivity disorder) diagnosed at about 6 years of age. Concomitant medication included ENULOSE 10 g/15 ml oral syrup: 1 ml orally 2 times a day for chronic constipation; Albuterol inhaler: 2 puffs inhaled every 4 to 6 hours, as needed for asthma and Albuterol nebulizer: 2.5 milligrams inhaled every 6 hours, as needed for asthma. She was vaccinated with MENVEO (batch number: M13058) intramuscularly on 04 Aug 2014. On the same day post vaccination her mother reported that a few hours after leaving the clinic a small reddened ring with some swelling and warmth developed at the injection site. She was referred to a primary care to report local reaction versus true vaccine allergy. Outcome of the events was completely recovered. Causality assessment was not reported. The events were reported as non-serious.
Age: 11.0
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Eye movement disorder, Immediate post-injection reaction, Lethargy, Posture abnormal, Presyncope
Clinical narrative: Case number PHHY2014US154750 is an initial spontaneous report received from a health professional via the Vaccine Adverse Events Reporting System website on 13 NOV 2014. this report refers to an 11-year-old male patient. His past medical history and concomitant medications were not reported. On 21 JUL 2014, the patient was vaccinated with MENVEO (batch number: not reported)with Hepatitis A vaccine (manufacturer and batch number: not reported) with the first dose of GARDASIL (other manufacturer, batch number: J009243, expiration date: 23 APR 2016) at a dose of 0.6 ml intramuscularly and with diphtheria, tetanus and acellular pertussis vaccine (other manufacturer, batch number: not reported). On 21 JUL 2014, immediately after the vaccinations, the patient's head rolled back and his eyes rolled back in his head. The patient experienced a vasovagal event. The patient was sitting during the injection and did not have any injury. The patient came back to the clinic shortly after and reported feeling lethargic. On 21 JUL 2014, the patient recovered from the events. The events were reported as non serious and causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US137324, is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS reference number: 539077) website on 10 OCT 2014. This report refers to a 12 year old male patient. He had no known drug allergies. Current condition included seasonal allergies, asthma reaction to exercise and allergens. Concomitant medication included Proair HFA, 90 mcg aerosol inhalation as needed for 30 days. He was vaccinated with MENVEO (batch number: A13030) intramuscular into right arm on 05 AUG 2014. On the same day he also received HAVRIX (batch number: YZ2F7, other manufacturer) intramuscular into right arm. On the same day after vaccination, patient right deltoid area where injection was given became extremely swollen from the shoulder down towards to the elbow. Also the injection site was hot to touch and very painful. Outcome of the event was unknown. Causality  assessment was not reported. The events were reported as non-serious.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Rash, Rash erythematous
Clinical narrative: Case number PHHY2014US122093 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 539165)  on 16 SEP 2014. This report refers to an 11 year old male patient. His medical history included allergies and asthma. His concomitant medication included multivitamin, Digestive Advantage for lactose intolerance and probiotics. On 06 AUG 2014, he was vaccinated with a meningococcal vaccine (manufacturer and batch number not reported) into left arm. On the same day after vaccination, he experienced red spots which appeared on his face and arms. The area of vaccination was all clear. He was treated with Benadryl at a dose of 25 mg every 06 hours until symptoms went away. The outcome was unknown. The HA reported the events as non-serious. Causality was not reported.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Erythema, Skin warm
Clinical narrative: Case number PHHY2014US137306, is an initial spontaneous report received from a consumer (patient mother) via Vaccine Adverse Event Reporting System (VAERS reference number: 539238) website on 10 OCT 2014. This report refers to a 12 year old male patient. His mother denied any pre-existing  conditions and illness at the time of vaccination. He was vaccinated with MENVEO (batch number: A13015) intramuscular into left arm on 06 AUG 2014. On the same day he also received BOOSTRIX (batch number: LF444, other manufacturer) intramuscular into left arm. On 07 AUG 2014, his mother reported that his arm was red and hot. He was monitored and applied  ice packs. Outcome of the event was unknown. Causality assessment was not reported. The events were reported as non-serious.
Age: 16.0
Sex: F
Vaccine: HEP, HEPA, HPV4, IPV, MMR, MNQ, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site pain, Pruritus, Skin lesion, Vaccination site swelling
Clinical narrative: Case number PHHY2014US154923 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 539284) website on 13 NOV 2014. This report refers to a 16 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M14022), ENGERIX-B (other manufacturer, batch number: AHBVC200AA), GARDASIL (J015378) and VARIVAX (other manufacturer, batch number: J013902); all vaccines administered in the left arm on 30 JUL 2014. On the same day, she also received ADACEL (other manufacturer, batch number: C4506BA), HAVRIX (other manufacturer, batch number: T933M), MMR II (other manufacturer, batch number: J011332) and IPOL (other manufacturer, batch number: J1731); all vaccines administered in the right arm. On an unknown date, she experienced red bump in the vaccination site of the left arm. She went to emergency room. Immunization reaction was ruled out as diagnosis. On 01 AUG 2014, she was diagnosed with left arm lesion and itching was treated with Atarax 25 mg thrice daily whenever required and she also took Bactrim DS twice daily for 10 days. She complained that the left arm was itchy and painful in site on 03 AUG 2014 at 1:24 PM. The outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was reported as not suspected to suspect vaccines.
Age: 25.0
Sex: F
Vaccine: MNQ
Symptoms: Chills, Headache, Migraine, Pyrexia
Clinical narrative: Case number PHHY2014US136014, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 539332) website on 10 OCT 2014. This report refers to a 25-year-old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12098) intramuscularly into left thigh on 01 AUG 2014. On 02 AUG 2014, she experienced fever, chills headache and migraine. Outcome of the events were reported as recovered. These events were reported as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Vaccination site oedema
Clinical narrative: Case number PHHY2014US136039, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 539333) website on 10 Oct 2014. This report refers to an 11-year-old male patient. His concurrent conditions included allergy to tree pollen, grass pollen, weed pollen, cat hair, dog hair, aspergillus and soybean. Concomitant medications included ALLEGRA, TENEX, ZOLOFT, CONCERTA and melatonin. He was vaccinated with MENVEO (batch number: M14031) intramuscularly into left arm on 05 Aug 2014. On the same day, he was also vaccinated with GARDASIL (batch number: K006449, other manufacturer) into right arm and BOOSTRIX (batch number: JA279, other manufacturer) into left arm, both intramuscularly. On 06 Aug 2014, one day after vaccinations, he developed edema and redness on his right and left arm where vaccination was administered. He had a visit to emergency room due to these events. Outcome of the events were reported as recovered. These events were reported as non-serious. Causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Local swelling, Pain, Skin warm
Clinical narrative: Case number PHHY2014US136091, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 539336) website on 10 OCT 2014. This report refers to a 12-year-old male patient. His medical history was not reported. Concomitant medication included Concerta . He was vaccinated with MENVEO (batch number: M13053) into right arm along with BOOSTRIX (batch number: LF444, other manufacturer) into left arm, both intramuscularly on 08 AUG 2014. On the same day, post vaccination, he experienced localized swelling, warmth and pain. He was treated with cefdinir 300 mg twice daily orally for 10 days. These events were reported as non-serious. Outcome of the events was reported as unknown. Causality of the events was not reported.
Age: 42.0
Sex: M
Vaccine: HEPAB, IPV, MMR, MNQ
Symptoms: Arthralgia, Asthenia, Myalgia, Pyrexia
Clinical narrative: Case number PHHY2014US136200, is an  initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 539337) website on 10 OCT 2014. This report refers to a 42-year-old male patient. His medical history was  not reported. Concomitant medication included Benadryl. He was vaccinated with MENVEO, (batch number: unknown) into left arm on 06 AUG 2014. On the same day, he was also vaccinated with TWINRIX (batch number: unknown, other manufacturer) into right arm; MMR (batch  number: unknown, other manufacturer) into right arm and Poliovirus vaccine inactivated (batch number: unknown, other manufacturer) into left arm. On 07 AUG 2014, one day after vaccinations, he experienced fever below 100 Fahrenheit (F), muscle aches, joint aches and weakness. Outcome of the events was reported as recovered. These events were reported as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pruritus, Vaccination site pain, Vaccination site pallor
Clinical narrative: Case number PHHY2014US154230 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 539369) website on 13 NOV 2014. This report refers to an 11 years old male patient. His current condition included headaches and allergic rhinitis and concomitant medications were Nasonex and ibuprofen. He was vaccinated with MENVEO (batch number: M13064) intramuscularly in the left arm deltoid on 06 AUG 2014. On 07 AUG 2014, he experienced itching at the vaccination site and local soreness at the left deltoid. On 08 AUG 2014, his mother reported that the area of redness at the site was 4 inches and he also had pallor and itching at the site in left deltoid. On 09 AUG 2014, he had a 16 cm circumferential area around the injection site. It was reported that when the patient visited emergency room, there was no redness, blotchy warm, swelling or tenderness noticed. He was treated with Desonate (desonide) gel to the applied area twice QD. The outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, TDAP
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Case number PHHY2014US143141 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 539463) website on 13 NOV 2014. This report refers to an 11 years old female patient. She had no know medical history and her concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M14024) in the left arm and GARDASIL (other manufacturer, batch number: J10668) in the left arm on 01 AUG 2014. She also received VAQTA (other manufacturer, batch number: K007791) in the right leg and BOOSTRIX (other manufacturer, batch number: L7J44) in the right arm on the same date. On 02 AUG 2014, she experienced a 10 cm x 10 cm erythematous, warm, pruritic area surrounding the vaccination sites in the left deltoid and the site was slightly tender and itchy. She had no secondary infection. She did not take any treatment and had no laboratory tests performed. The outcome was reported as complete recovery. The events were reported as non-serious. The causality of the event was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Pain in extremity
Clinical narrative: Case number PHHY2014US153121 is an initial spontaneous report via the Vaccine Adverse Event Reporting System (VAERS reference number: 539501) website on 13 NOV 2014. This report refers to an 18 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M14024) intramuscularly on 30 JUL 2014. She had pain and achiness in bilateral legs on 30 JUL 2014 in PM and it worsened on 01 AUG 2014. She contacted doctor's office and took ibuprofen. The outcome was reported as complete recovery on 03 AUG 2014. The event was reported as non-serious. The causality of the event was not reported.
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2014US153105 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 539562) website on 13  NOV 2014. This report refers to a 13 years old male patient. His medical history and concomitant medications was not reported. He was vaccinated with MENVEO (batch number: M14023) intramuscularly in the left arm on 11 AUG 2014. On 11 AUG 2014, he experienced swelling and redness at injection site and he went to emergency room. The swelling was at an area of 3.25 inches x 2.5 inches. The outcome was reported as complete recovery. The events were reported as non-serious. The causality of the event was not reported.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Erythema, Induration, Pain in extremity
Clinical narrative: Case number PHHY2014US122008, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 539617) website on 16 SEP 2014. This report refers to a 12-year-old male patient. Past medical history and concomitant medication was not reported. He was vaccinated with meningococcal vaccine INN (manufacturer and batch number unknown) along with GARDASIL (batch number: unknown, other manufacturer) both into left arm on 11 AUG 2014., On the same day, post vaccination, he developed pain, hard and red circle of area 3 inches in diameter on arm for two days so far. Events were reported as non-serious. Outcome of the events was reported as condition unchanged as of 12 AUG 2014. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Loss of consciousness, Pallor, Presyncope
Clinical narrative: Case number PHHY2014US149492, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 539813) website on 13 NOV 2014. This report refers to an 11-year-old male patient. Historical condition included foot fracture in 2008. He had allergy to tree nuts (pecans, walnuts). Concomitant medications included fluoride chew tab and children's multivitamin chew tab. He was vaccinated with MENVEO (batch  number: A14023) and BOOSTRIX (batch number: 9B23Z3, other manufacturer) both intramuscular into right arm on 12 AUG 2014. No illness at time of visit. patient came in for 3 injections but after first 2 injections were given, he leaned forward and passed out. Mother and nurse caught patient when leaning forward (no fall). Patient laid back on exam table, was coherent within 2-3 seconds. He was very pale and his feet was elevated and given juice to drink. Patient was laid on table for a while, sat up for a while and stood after with no incident, left in good condition. The third injection was held off for now per provider. The patient was in the office for 35 min post injection, for monitoring. Provider believed that the patient had a vasovagal response to getting vaccines. Outcome of the event was recovered. Events were reported as non-serious. Causality assessment was not reported.
Age: 18.0
Sex: M
Vaccine: MEN
Symptoms: Back pain, Headache, Nausea, Photophobia
Clinical narrative: Case number PHHY2014US121969, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 539829) website on 16 Sep 2014. This report refers to an 18-year-old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with meningococcal vaccine INN (manufacturer and batch number unknown) on 13 Aug 2014. On 14 Aug 2014, he experienced nausea initially in middle of the night, and then he woke up with bad headache, photophobia and back pain. These events were suspected as self limited immune reaction (not allergic). The events were reported as non-serious. Outcome and causality of the events were not reported.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US153180 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 539886) website on 13 NOV 2014. This report refers to a 16 years old female patient. Her medical history was not reported and her concomitant medication included Augmentin. She was vaccinated with MENVEO (batch number: XC14021) intramuscularly in the left arm on 12 AUG 2014. On the same day after vaccination, she experienced some swelling in the site. It was reported that swelling increased the day after vaccination and it became red and warm measuring 10 cm x 9 cm in the site of the left arm. The outcome was reported as unknown. The events were reported as non-serious. The causality of the event was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Dizziness
Clinical narrative: Case number PHHY2014US153102 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (VAERS reference number: 539907) website on 13 NOV 2014. This report refers to an 11 years old female patient. Her medical history and concomitant medications was not reported. She was vaccinated with MENVEO (batch number: A14023) and GARDASIL (other manufacturer, batch number: J009788), both vaccines administered intramuscularly in the left arm on 13 AUG 2014. On 13 AUG 2014, 5 to 10 minutes after receiving GARDASIL, she felt dizzy. The final outcome was reported as complete recovery. The events were reported as non-serious. The causality of the event was not reported.
Age: 49.0
Sex: M
Vaccine: HEPA, MNQ, TDAP, YF
Symptoms: Musculoskeletal pain, Periarthritis
Clinical narrative: Case number PHHY2014US141464, is an initial spontaneous report received from a consumer (patient) via Vaccine Adverse Event Reporting System (VAERS reference number: 540049) website on 28 OCT 2014. This report refers to a 49 year old male patient. His medical history and concomitant medication was not reported. He was vaccinated with Meningococcal ACWY vaccine INN (manufacturer and batch number: unknown) on 28 FEB 2014. On the same day he also received diphtheria and tetanus toxoids and acellular pertussis vaccine (manufacturer and batch number: unknown) into right arm, hepatitis A vaccine (manufacturer and batch number unknown) into right arm and yellow fever vaccine (manufacturer and batch number unknown). One week after vaccination the patient suffered from shoulder pain. He visited health care professionals and attended physical therapy from adhesive capsulitis. He went to the emergency room. The outcome of the events was condition unchanged as of 15 AUG 2014. Causality assessment was not reported. The events were reported as non-serious.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2014US153139, an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540065) website on 13 NOV  This report refers to an 11-year-old male patient. Historical conditions and current illness were none. No concomitant medication was reported. He was vaccinated with MENVEO (batch number: M12131), along with GARDASIL (batch number: J010668) and BOOSTRIX (batch number: A54AL) intramuscularly on 13 AUG 2014, the patient experienced redness and swelling of upper arm at site of immunization. The outcome of the events was unknown. The events were reported as non-serious. Causality was not reported.
Age: 12.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: No adverse event, Product reconstitution issue
Clinical narrative: Case number PHHY2014US153149, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540067) website on 13 NOV 2014. This report refers to a 12-year-old female patient. Historical  conditions and current illness were none. Concomitant medication included GARDASIL(batch number: J006236) and BOOSTRIX (batch number: N4352). She was administered only MenCYW-135 liquid component of MENVEO (batch number: M13017) without being reconstituted with MenA, intramuscularly on 13 AUG 2014. No adverse event was reported following the administration error (inappropriate preparation of medication).
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Case number PHHY2014US153181, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540123) website on 13 Nov 2014. This report refers to an 11-year-old male patient. Historical conditions were not reported. Current illness was none. Concomitant medication was none. No known drug allergies. The patient was an adopted child; no family history was available. He was vaccinated with MENVEO (batch number: X14022), along with GARDASIL (batch number: H021861) and BOOSTRIX (batch number: LF444) intramuscularly into the right arm on 13 Aug 2014. On 14 Aug 2014, about 24 hours after receiving vaccines, he developed pain and swelling at the site of right deltoid. He had no relief  with interventions and noticed swelling increased. The site was red, swollen and warm to touch. On 15 Aug 2014, he returned to clinic. Ice was applied to right deltoid area 10 cm in diameter. The patient left with father in good spirits and ambulatory. The outcome of the events was unknown. The events were reported as non-serious. Causality was not reported.
Age: 15.0
Sex: F
Vaccine: HEPA, HPV4, MNQ, VARCEL
Symptoms: Erythema, Pyrexia
Clinical narrative: Case number PHHY2014US153197, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540170) website on 13 NOV 2014. This report refers to a 15-year-old female patient. Historical conditions were not reported. Concomitant medications included Prozac and Wellbutrin. She was vaccinated with MENVEO (batch number: M13054) along with HAVRIX (batch  number: 5954N), GARDASIL (batch number: J009243) and VARIVAX (batch number: J013730) on 30 JUL 2014. On 31 JUL 2014 she developed an area of erythema 1 1/2 into 1 1/2 inches and fever of 99.4. The area of redness enlarged to three inches overnight. The outcome of the events was complete recovery. The event was reported as non-serious. Causality was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Induration
Clinical narrative: Case number PHHY2014US15.205, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540181) website on 13 NOV 2014. This report refers to an 18-uyear-old female patient. Historical conditions and current illness were none. No concomitant medication was reported. she was vaccinated with MENVEO (batch number: M14024) intramuscularly on 12 AUG 2014. On the same day after vaccination, she experienced induration. She went to emergency room. The outcome of the event was unknown. The event was reported as non-serious. Causality was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Injection site erythema, Injection site reaction, Injection site swelling, Injection site warmth, Skin tightness
Clinical narrative: Case number PHHY2014US153266 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System on 13 Nov 2014. This report refers to a 11 year old female patient. Her past medical history and concomitant medications were not reported. She was treated with penicillin and sulfa drugs in the past. Her vaccination history included vaccination with TDAP (other manufacturer, batch number: not reported) on an unspecified date. She underwent a purified protein derivative skin test (PPD test) on an unspecified date. On 11 Aug 2014, she was vaccinated with MENVEO (batch number: A14041) into her right arm and with BOOSTRIX (other manufacturer, batch number: 7KM4D) into her left arm. On 12 Aug 2014, her right upper arm was swollen, red, and hot and she felt like her skin was stretching. She visited the emergency room on an unspecified date. The patient completely recovered from the events on an unspecified date. The events were reported as non serous and the causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Tuberculin test
Clinical narrative: Case number PHHY2014US153266 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System on 13 Nov 2014. This report refers to a 11 year old female patient. Her past medical history and concomitant medications were not reported. She was treated with penicillin and sulfa drugs in the past. Her vaccination history included vaccination with TDAP (other manufacturer, batch number: not reported) on an unspecified date. She underwent a purified protein derivative skin test (PPD test) on an unspecified date. On 11 Aug 2014, she was vaccinated with MENVEO (batch number: A14041) into her right arm and with BOOSTRIX (other manufacturer, batch number: 7KM4D) into her left arm. On 12 Aug 2014, her right upper arm was swollen, red, and hot and she felt like her skin was stretching. She visited the emergency room on an unspecified date. The patient completely recovered from the events on an unspecified date. The events were reported as non serous and the causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: HEPA, HPV4, MNQ, TDAP, VARCEL
Symptoms: No adverse event, Product reconstitution issue
Clinical narrative: Case number PHHY2014US155337, is an initial spontaneous report from Vaccine Adverse Event Reporting System (VAERS, reference number: 540386) website on 13 NOV 2014. This report refers to a 12 year old male patient. Historical condition was not reported. Concomitant vaccination included VAQTA (other manufacturer, batch number: J005010) intramuscularly in left arm, GARDASIL (other manufacturer, batch number: U4939AA) intramuscularly in left arm and VARIVAX (other manufacturer, batch number: J013900) subcutaneously in left arm all on 14 AUG 2014. The patient was inadvertently vaccinated only with the powder component of MENVEO (batch number: M14123) mixed with sterile diluent via intramuscular route in right arm on 14 AUG 2014. No adverse event was reported following this administration error (inappropriate preparation of medication).
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site oedema, Injection site pain, Injection site pruritus
Clinical narrative: Case number PHHY2014US148740, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540403) website on 13 NOV 2014. This report refers to a 12-year-old male patient. Medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M14031) intramuscularly  in right arm on 16 AUG 2014. On 17 AUG 2014, the patient developed erythema and edema of area 6 inch x 8 inch on right upper arm. The area was warm to tuch, mildly tender and pruritic. Erythema suggests moderal to severe allergic response/possible cellulitis. No systemic symptoms of allergic reaction were reported and the patient was stable at time of assessment on 18 AUG 2014 at 04:56 PM. The patient was referred to urgent care for evaluation due to these events. It was reported that the erythema improved since onset. Final outcome of the events was reported as unknown. These events reported as non-serious. Causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site warmth
Clinical narrative: Case number PHHY2014US148740, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540403) website on 13 NOV 2014. This report refers to a 12-year-old male patient. Medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M14031) intramuscularly  in right arm on 16 AUG 2014. On 17 AUG 2014, the patient developed erythema and edema of area 6 inch x 8 inch on right upper arm. The area was warm to tuch, mildly tender and pruritic. Erythema suggests moderal to severe allergic response/possible cellulitis. No systemic symptoms of allergic reaction were reported and the patient was stable at time of assessment on 18 AUG 2014 at 04:56 PM. The patient was referred to urgent care for evaluation due to these events. It was reported that the erythema improved since onset. Final outcome of the events was reported as unknown. These events reported as non-serious. Causality of the events was not reported.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Dizziness, Hyperhidrosis, Visual impairment
Clinical narrative: Case number PHHY2014US149703, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540406) website on 13 NOV 2014. This report refers to a 12-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. He was vaccinated with MENVEO (batch number: A14041) intramuscularly, along with GARDASIL (batch number: J006236), ADACEL (batch number: U4939AA) and VARIVAX (batch number: J003542) on 19 AUG 2014. On the same day after vaccination, he complained of dizziness and vision change. He became diaphoretic. Blood Pressure was 99/68, Heart Rate was 68, SP02 98% and respiration was 16. He was given an ice pack to place under arm pit. He was monitored for an additional 20-40 minutes and he left the clinic in stable condition with all signs and symptoms described as resolved. The events were reported as non-serious. causality was not reported.
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Erythema, Swelling
Clinical narrative: Case number PHHY2014US153322 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 540440) on 13 NOV 2014. This report refers to a female patient of an unspecified age. Her past medical history and concomitant medications were not reported. On 04 AUG 2014 she was vaccinated with MENVEO (batch number: M14024) into her left arm, with GARDASIL (other manufacturer, batch number: K0050783) into her right arm and with ADACEL (other manufacturer, batch number:U4902BA) into her left arm. On 05 AUG 2014, she had a raised red area measuring 6-7 cm. On an unspecified date, she visited the emergency room. She completely recovered from the events on an unspecified date. The events were reported as non-serious and causality of the events was not reported.
Age: 17.0
Sex: F
Vaccine: HEP, MNQ
Symptoms: No adverse event, Wrong technique in product usage process
Clinical narrative: Case number PHHY2014US155236 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Events Reporting System website (VAERS ID: 540522) on 12 NOV 2014. This report refers to a 17 year old female patient. Her past medical history and concomitant medications were not reported. On 14 AUG 2014, the patient was vaccinated with MENVEO (batch number: M14023) into her right arm and with RECOMBIVAX HB (batch number: J006511) into her left arm. On the same day, three other patients were vaccinated with MENVEO and one diluent remained in the box with no powder (Men A lyophilized powder). Research did not provide which dose was given incorrectly. All the four clients were notified to get revaccinated. No adverse events were reported following this medication error (wrong technique in drug usage process).
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site swelling, Medication error
Clinical narrative: Case number PHHY2014US151031, is an initial spontaneous report received from the Adverse Event Reporting System (VAERS reference number: 540621) website on 13 NOV 2014. This report refers to a 12-year-old female patient. Medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A14044) subcutaneously into left arm on 18 AUG 2014. On 19 AUG 2014, the patient developed swollen arm where the vaccine was given. Outcome of the event was reported as recovered. The event was reported as non-serious. Causality of the event was not reported.
Age: 1.0
Sex: F
Vaccine: MMR, MNQ
Symptoms: Hyperaesthesia, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Case number PHHY2014US144473, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 540635) website on 28 OCT 2014. This report refers to a 01-year-old female patient. On 20 AUG 2014, she was vaccinated with meningococcal vaccine (manufacturer and batch number: not reported, so conservatively coded as meningococcal ACYW vaccine INN) in the right leg along with MMR (( (other manufacturer and batch number not reported) in the left leg. On 21 AUG 2014, she experienced sore and swelling at injection site. She was sensitive to the touch. She had fever of 101.7 F (rectal) at 05:30 AM. She was administered with 3.75 ml acetaminophen oral suspension at 05:30 AM and fever reduced to 100.7 F (rectal) by 08:30 AM and again she was administered with 3.75 ml, acetaminophen oral suspension at 08:45 AM. The final outcome of the events reported as recovered. The events reported as non-serious. The causality of the events was not reported.